2016newlogowords
AACT/ABAT Journal Club April 2020: Kratom's abuse potential and associated fatalities. Should we be concerned, or leaf it alone? Enduring Material
Mr pencil

How would you like your name to appear on your certificate?



Agreement
By completing this form, you attest that you have attended the activity in its entirety.
Was the educational content of value to you?
Was the educational content scientifically sound?
If no, please explain...
Did you perceive any commercial bias or influence in the educational content?
If yes, please explain...
Did this activity improve your Skills or Strategy?
If yes, how...
Do you think what you learned will benefit you in your practice?
If yes, how...
Tell us what was good or bad about any part of the educational activity, content, speakers, materials, anything
What questions are you having in your practice that you would like to see addressed in an educational activity?
PHARMACISTS: If you do not provide your NABP ID AND your DATE OF BIRTH, your hours will not be uploaded to CPE Monitor.
(CPE Monitor) NABP e-Profile ID (ePID) - Example 123456:
(CPE Monitor) Date of Birth (MM/DD) - Example September 24 would be 0924: 
Please rate Craig Cocchio
Content/Teaching Methods
Presentation/Handouts
Relevance of Content to Objectives
Independence, Objectivity, Balance, Scientific Rigor
Please rate James Leonard
Content/Teaching Methods
Presentation/Handouts
Relevance of Content to Objectives
Independence, Objectivity, Balance, Scientific Rigor
Were the learning objectives met?
Describe the abuse potential of kratom according to Factors 1, 4, 5, and 6 from the controlled substances 8 factors analysis.
Describe the major limitations in the literature on kratom as it applies to Factor 6 "what, if any, risk there is to the public health."
Describe the nature of deaths reported as associated with. the use of kratom.
Evaluate the current DEA position of Scheduling Kratom (Mitragynine).
When you viewed this webinar, were you in a group or by yourself?
If in a group, with how many people?
Comments:
Mr question
Provided by amedco